Pharmacotherapy for hyperuricemia in hypertensive patients
Source: Cochrane
Area: Evidence > Disease Focused Reviews
Background
High blood pressure represents a major public health problem. Worldwide, approximately one fourth of the adult population has hypertension. Epidemiological and experimental studies suggest a linkage between hyperuricemia and hypertension. Hyperuricemia affects 25-40 % of patients with untreated hypertension. A much lower prevalence has been reported in normotensives or in the general population. However, whether lowering serum uric acid (SUA) might lower blood pressure (BP) is an unanswered question.
Objectives
To determine whether uric acid lowering agents reduce BP in patients with primary hypertension.
Search methods
Electronic searches of the following sources were performed without language restriction: Cochrane Hypertension Group Specialised Register (1946 to May 2012), Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, 2012 Issue 4), MEDLINE (1946 to May 2012), EMBASE (1974 to May 2012), LILACS ...
Source: NeLM - Cardiovascular Medicine - Category: Cardiology Source Type: news
More News: Cardiology | Cardiovascular | Databases & Libraries | Epidemiology | Health | Heart | Hypertension | International Medicine & Public Health | Study